Verkäufer
Books From California, Simi Valley, CA, USA
Verkäuferbewertung 4 von 5 Sternen
AbeBooks-Verkäufer seit 14. August 2001
Cover and edges may have some wear. Bestandsnummer des Verkäufers mon0003395805
In 2002, the U.S. Food and Drug Administration (FDA) launched the Pharmaceutical Quality for the 21st Century Initiative to encourage adoption of innovative technologies that would lead to an agile, flexible pharmaceutical manufacturing sector. The goal was to encourage a transition to manufacturing processes and approaches that could produce high-quality drugs reliably without extensive regulatory oversight. Much progress has been made toward that goal as the industry has developed and advanced new technologies, but more progress is required as recent natural disasters and the coronavirus pandemic have revealed vulnerabilities in supply chains and highlighted the need to modernize pharmaceutical manufacturing further.
At the request of the FDA Center for Drug Evaluation and Research (CDER), Innovations in Pharmaceutical Manufacturing on the Horizon identifies emerging technologies - such as product technologies, manufacturing processes, control and testing strategies, and platform technologies - that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by CDER. This report describes many innovations to modernize the manufacture of drug substances and drug products, to advance new control approaches, and to develop integrated, flexible, and distributed manufacturing networks within 5-10 years.
Titel: Innovations in Pharmaceutical Manufacturing ...
Verlag: National Academies Press
Erscheinungsdatum: 2021
Einband: paperback
Zustand: Very Good
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
paperback. Zustand: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book. Bestandsnummer des Verkäufers ERICA82903090886746
Anzahl: 1 verfügbar